Genetic studies of IgG4-RD identified two susceptibility loci, the human leukocyte antigen (HLA)-DRB1 and Fc gamma receptor 2B (FCGR2B) (81). This evidence concerns the gene HLA-DRB1 and immunoglobulin G4-related sclerosing disease.